{"id":172,"date":"2022-08-18T03:22:54","date_gmt":"2022-08-18T03:22:54","guid":{"rendered":"https:\/\/oncohem.com.ec\/?page_id=172"},"modified":"2022-09-10T01:48:31","modified_gmt":"2022-09-10T01:48:31","slug":"dr-mauricio-riofrio","status":"publish","type":"page","link":"https:\/\/oncohem.com.ec\/index.php\/dr-mauricio-riofrio\/","title":{"rendered":"Dr Mauricio Riofrio"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"172\" class=\"elementor elementor-172\">\n\t\t\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-df225e8 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"df225e8\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-3abb7df\" data-id=\"3abb7df\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-71af244 elementor-widget elementor-widget-image\" data-id=\"71af244\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.7.2 - 21-08-2022 *\/\n.elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=\".svg\"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block}<\/style>\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"200\" height=\"300\" src=\"https:\/\/oncohem.com.ec\/wp-content\/uploads\/2022\/08\/Quality_10B-1-200x300.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/oncohem.com.ec\/wp-content\/uploads\/2022\/08\/Quality_10B-1-200x300.jpg 200w, https:\/\/oncohem.com.ec\/wp-content\/uploads\/2022\/08\/Quality_10B-1-684x1024.jpg 684w, https:\/\/oncohem.com.ec\/wp-content\/uploads\/2022\/08\/Quality_10B-1-768x1150.jpg 768w, https:\/\/oncohem.com.ec\/wp-content\/uploads\/2022\/08\/Quality_10B-1-1025x1536.jpg 1025w, https:\/\/oncohem.com.ec\/wp-content\/uploads\/2022\/08\/Quality_10B-1-1367x2048.jpg 1367w, https:\/\/oncohem.com.ec\/wp-content\/uploads\/2022\/08\/Quality_10B-1-scaled.jpg 1709w\" sizes=\"auto, (max-width: 200px) 100vw, 200px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-c9c42b0\" data-id=\"c9c42b0\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-a4b4e8e elementor-widget elementor-widget-heading\" data-id=\"a4b4e8e\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.7.2 - 21-08-2022 *\/\n.elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px}<\/style><h2 class=\"elementor-heading-title elementor-size-default\">Dr. Mauricio Augusto Riofr\u00edo Riofr\u00edo<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-feb5966 elementor-widget elementor-widget-text-editor\" data-id=\"feb5966\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.7.2 - 21-08-2022 *\/\n.elementor-widget-text-editor.elementor-drop-cap-view-stacked .elementor-drop-cap{background-color:#818a91;color:#fff}.elementor-widget-text-editor.elementor-drop-cap-view-framed .elementor-drop-cap{color:#818a91;border:3px solid;background-color:transparent}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap{margin-top:8px}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap-letter{width:1em;height:1em}.elementor-widget-text-editor .elementor-drop-cap{float:left;text-align:center;line-height:1;font-size:50px}.elementor-widget-text-editor .elementor-drop-cap-letter{display:inline-block}<\/style>\t\t\t\t<h6><strong>Onc\u00f3logo Clinico<\/strong><\/h6>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-63d86fd elementor-widget elementor-widget-text-editor\" data-id=\"63d86fd\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><strong>Tel\u00e9fonos:<\/strong> 04-6005681\/ \u00a0099 929 8384<\/p><p><strong>E-mail:<\/strong> m_riofrio@hotmail.com<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-9aaa592 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"9aaa592\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-12b5958\" data-id=\"12b5958\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-46d5e30 elementor-widget elementor-widget-heading\" data-id=\"46d5e30\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Experiencia Laboral<\/h3>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2abb276 elementor-widget elementor-widget-text-editor\" data-id=\"2abb276\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<ul><li>1985-1991: Medical Studies at Catholic University of Guayaquil.<\/li><li>1991-1992: Pregrade Practice at Social Security Hospital and Alejandro\u2019s MANN Child Hospital, Guayaquil \u2013 Ecuador<\/li><li>1992: Internal Medicine and Surgery Doctoral Degree of the Ecuadorian Republic.<\/li><li>1992-1993: Medical Community Practice for the Ecuadorian Public Health Minister.<\/li><li>1993-1996: Resident at Internal Medicine Department of M.H.Alc\u00edvar Hospital.<\/li><li>1994-1996: Practice Professor of Clinical Oncology at Catholic University of Guayaquil.<\/li><li>1994-1996: Fellow of Internal Medicine Department at National Ecuadorian Cancer Institute, SOLCA Guayaquil<\/li><li>1996-1997: Foreign Resident of Paris Medical College.<\/li><li>1997-1998: Resident of the Hematology, Immunology and Tumoral Disease Department at Paul Brousse Hospital (Villejuif).<\/li><li>1998: \u00ab Certificat C2 Regulations Cellulairs, Pathologie des Regulations\u00bb Biology and Medical Sciences Matrix.<\/li><li>1998: Certification of Specialist Formation in Clinical Oncology delivered by the Paris XI University.<\/li><li>Feb 1999-October 2000: Senior Resident of Medicin Department at Gustave Roussy Institut.<\/li><li>November 2000-October 2001: Chef de Clinique at Oncologist and Hematologist Service of Paul Brousse Hospital, Paris XI University<\/li><li>1999-2001: ESMO (European Society of Medical Oncology) Fellowship winner.<\/li><li>August 2002-October 2012 Head of Clinical Oncology Service at Hospital Naval Guayaquil<\/li><li>Since November 2012 Head of Clinical Oncology Service at M.H. Alcivar Hospital<\/li><\/ul>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-72a5cb0 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"72a5cb0\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-b009f9d\" data-id=\"b009f9d\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-a5d2877 elementor-widget elementor-widget-heading\" data-id=\"a5d2877\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Publications and Posters<\/h3>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1cfafd3 elementor-widget elementor-widget-text-editor\" data-id=\"1cfafd3\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<ul><li>Cervix Carcinoma, In Situ and IA Stade, prognostic and treatment. Oral presentation VII Ecuadorian National Congress of Cancerology, Guayaquil July 1992.<\/li><li>Invaginaci\u00f3n intestinal diagnosticada y reducida por enema baritado. Actas M\u00e9dicas; Vol. 4 No. 1, 1994 pag.57-61.<\/li><li>Infarto agudo de miocardio, estudio de 4 a\u00f1os en la unidad de terapia intensiva del Hospital M.H. Alcivar. Actas M\u00e9dicas; Vol. 4 No. 1, 1994 pag. 90-96.<\/li><li>Paludismo y derrame pleural, estudio de 2 casos. Actas M\u00e9dicas; Vol. 4 No. 2, 1994 pag. 144-148.<\/li><li>Valeur predictive du taux initial de bilirubinemie et de son elevation precoce et transitoire au cours des chimiotherapies comportant du CPT-11, dans la survenue de neutropenie et diarrhee severes. Poster discution XVIIeme Forum de Cancerologie, Paris Mai 1997.<\/li><li>Bilirubin: Baseline value and transient increase of total bilirubin (BIL) may be used as good predictor of CPT-11\u2019s toxicity. Oral presentation ECCO 9 Hamburg September 1997.<\/li><li>Oxaliplatin (L-OHP)\/CPT11 combination every two weeks: Preliminary results of a phase I study in advanced digestive malignancies. Poster presentation at AACR eighty-ninth Annual Meeting New Orleans, LA \u2013 March 1998.<\/li><li>Ecteinascidin-743 (ET-743) 24 hours continuous intravenous infusion (CI) phase I study in solid tumors (ST) patients (pts). Poster presentation at AACR eighty-ninth Annual Meeting New Orleans, LA \u2013 March 1998.<\/li><li>Baseline serum bilirubin, a good predictor of CPT-11 neutropenia. A pharmacokinetic\/Pharmacodynamic (pk\/pd) correlation. Poster presentation at AACR eighty-ninth Annual Meeting New Orleans, LA \u2013 March 1998.<\/li><li>Bilirubin (BIL) and SN-38 Metabolism: Pharmacodynamics of CPT-11 Toxicity. Proceedings of ASCO Thirty-fourth Annual Meeting. May 1998 Los Angeles, CA.<\/li><li>Ecteinascidin-743 (ET-743) 24 hours continuous infusion (CI): Clinical and pharmacokinetic phase I study in solid tumor patients (PTS). Preliminary results. Poster presentation ASCO Thirty-fourth Annual Meeting. May 1998 Los Angeles, CA.<\/li><li>CPT11\/Oxaliplatin (L-OHP) every two weeks: A phase I study in patients (PTS) with advanced digestive tumors. Poster presentation ASCO Thirty-fourth Annual Meeting. May 1998 Los Angeles, CA.<\/li><li>CPT11\/Oxaliplatin (L-OHP): Thimidylate sinthase (TS) independent combination with efficacy in 5-FU refractory colorectal cancer (CRC) patients (PTS). Poster presentation ASCO Thirty-fourth Annual Meeting. May 1998 Los Angeles, CA.<\/li><li>Bilirubin (BIL) and SN-38: Pharmacokinetic\/Pharmacodynamics correlation. Poster presentation at 10 th NCI-EORTC symposium on new drugs in cancer therapy. June 1998 Amsterdam.<\/li><li>Ecteinascidin-743 (ET-743) 24-hour continuous intravenous infusion (CI) phase I study in solid tumors (ST) patients. Poster presentation at 10 th NCI-EORTC symposium on new drugs in cancer therapy. June 1998 Amsterdam.<\/li><li>CPT-11\/oxaliplatin (L-OHP) combination: Comparison of the toxicity of two schedules of administration. Poster presentation at 10 th NCI-EORTC symposium on new drugs in cancer therapy. June 1998 Amsterdam.<\/li><li>Oxaliplatin (L-OHP)\/CPT 11 combination every two weeks. Results of an ongoing phase I study in advanced digestive malignancies. Poster presentation ESMO 23rd congress, November 1998 \u2013 Athens, Greece.<\/li><li>Ecteinascidin-743 (ET-743) 24 hours continuous infusion (CI): Clinical and pharmacokinetic phase I study progressive report. Poster presentation ESMO 23rd congress, November 1998 \u2013 Athens, Greece.<\/li><li>Ecteinascidin-743(ET- 743) 24 hours continuous infusion (CI): Clinical and pharmacokinetic phase I study, final report. Poster presentation ASCO Thirty-fifth annual meeting. May 1999 Atlanta GA.<\/li><li>Facteurs Pronostics du Cancer du Sein et Facteurs Pr\u00e9dictifs de la Reponse au Traitement. La Lettre du Canc\u00e9rologue ; Fevrier 2000, Vol. IX n\u00b0 1, pag. 29-35. 3.<\/li><li>Phase I and pharmacokinetic study of ecteinascidin-743, a new marine compound, administered as a 24-hour continuous infusion in patients with solid tumors.J Clin Oncol. 2001 Mar 1;19(5):1256-65.<\/li><li>Ecteinascidin-743: a marine-derived compound in advanced, pretreated sarcoma patients\u2013preliminary evidence of activity.J Clin Oncol. 2001 Mar 1;19(5):1248-55.<\/li><li>Single-agent estramustine phosphate (EMP) is active in advanced breast cancer after failure with anthracyclines and taxanes.Ann Oncol. 2001 Sep;12(9):1265-8.<\/li><li>Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma.Cancer. 2001 Nov 1;92(9):2267-72.<\/li><li>Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients.J Clin Oncol. 2004 Mar 1;22(5):890-9.<\/li><li>A phase II study of Yondelis (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer.Br J Cancer. 2006 Jun 5;94(11):1610-4.<\/li><\/ul><p>\u00a0<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Dr. Mauricio Augusto Riofr\u00edo Riofr\u00edo Onc\u00f3logo Clinico Tel\u00e9fonos: 04-6005681\/ \u00a0099 929 8384 E-mail: m_riofrio@hotmail.com Experiencia Laboral 1985-1991: Medical Studies at [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":""},"class_list":["post-172","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/oncohem.com.ec\/index.php\/wp-json\/wp\/v2\/pages\/172","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oncohem.com.ec\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/oncohem.com.ec\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/oncohem.com.ec\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/oncohem.com.ec\/index.php\/wp-json\/wp\/v2\/comments?post=172"}],"version-history":[{"count":17,"href":"https:\/\/oncohem.com.ec\/index.php\/wp-json\/wp\/v2\/pages\/172\/revisions"}],"predecessor-version":[{"id":814,"href":"https:\/\/oncohem.com.ec\/index.php\/wp-json\/wp\/v2\/pages\/172\/revisions\/814"}],"wp:attachment":[{"href":"https:\/\/oncohem.com.ec\/index.php\/wp-json\/wp\/v2\/media?parent=172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}